Kobayashi, E.; Kondo, S.; Dochi, H.; Moriyama-Kita, M.; Hirai, N.; Komori, T.; Ueno, T.; Nakanishi, Y.; Hatano, M.; Endo, K.;
et al. Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target. Cancers 2022, 14, 2826.
https://doi.org/10.3390/cancers14122826
AMA Style
Kobayashi E, Kondo S, Dochi H, Moriyama-Kita M, Hirai N, Komori T, Ueno T, Nakanishi Y, Hatano M, Endo K,
et al. Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target. Cancers. 2022; 14(12):2826.
https://doi.org/10.3390/cancers14122826
Chicago/Turabian Style
Kobayashi, Eiji, Satoru Kondo, Hirotomo Dochi, Makiko Moriyama-Kita, Nobuyuki Hirai, Takeshi Komori, Takayoshi Ueno, Yosuke Nakanishi, Miyako Hatano, Kazuhira Endo,
and et al. 2022. "Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target" Cancers 14, no. 12: 2826.
https://doi.org/10.3390/cancers14122826
APA Style
Kobayashi, E., Kondo, S., Dochi, H., Moriyama-Kita, M., Hirai, N., Komori, T., Ueno, T., Nakanishi, Y., Hatano, M., Endo, K., Sugimoto, H., Wakisaka, N., & Yoshizaki, T.
(2022). Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target. Cancers, 14(12), 2826.
https://doi.org/10.3390/cancers14122826
